<DOC>
	<DOC>NCT01736735</DOC>
	<brief_summary>This is a placebo-controlled study to determine the effect of CLP in heart failure subjects with fluid overload.</brief_summary>
	<brief_title>Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Selected Age 21 years or older at randomization Heart failure with at least one of the following signs of current fluid overload: 1. Peripheral (or sacral) edema &gt;1+ or ascites during screening or on day of randomization 2. Pulmonary congestion as determined by chest Xray during the screening period Ambulatory and able to perform the 6minute walk test Selected Participation in another clinical trial of an investigational or marketed drug within 30 days or 5 halflives (whichever is longer) preceding screening Any hospitalization or unscheduled outpatient decongestion therapy using IV diuretics, ultrafiltration, or paracentesis within 8 weeks prior to or during screening Coronaryartery bypass graft, percutaneous intervention (e.g., cardiac, cerebrovascular, aortic), or major surgery including thoracic and cardiac, within 2 months prior to or during screening or anticipated need during study participation Heart transplant recipient, or anticipated need for transplant or LVAD during study participation Any of the following events having occurred within 8 weeks prior to or during screening: myocardial infarction, transient ischemic attack, stroke, or acute coronary syndrome as judged by the Investigator</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>